TOIP1_HUMAN - dbPTM
TOIP1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TOIP1_HUMAN
UniProt AC Q5JTV8
Protein Name Torsin-1A-interacting protein 1
Gene Name TOR1AIP1
Organism Homo sapiens (Human).
Sequence Length 583
Subcellular Localization Nucleus inner membrane
Single-pass membrane protein .
Protein Description Required for nuclear membrane integrity. Induces TOR1A and TOR1B ATPase activity and is required for their location on the nuclear membrane. Binds to A- and B-type lamins. Possible role in membrane attachment and assembly of the nuclear lamina..
Protein Sequence MAGDGRRAEAVREGWGVYVTPRAPIREGRGRLAPQNGGSSDAPAYRTPPSRQGRREVRFSDEPPEVYGDFEPLVAKERSPVGKRTRLEEFRSDSAKEEVRESAYYLRSRQRRQPRPQETEEMKTRRTTRLQQQHSEQPPLQPSPVMTRRGLRDSHSSEEDEASSQTDLSQTISKKTVRSIQEAPVSEDLVIRLRRPPLRYPRYEATSVQQKVNFSEEGETEEDDQDSSHSSVTTVKARSRDSDESGDKTTRSSSQYIESFWQSSQSQNFTAHDKQPSVLSSGYQKTPQEWAPQTARIRTRMQNDSILKSELGNQSPSTSSRQVTGQPQNASFVKRNRWWLLPLIAALASGSFWFFSTPEVETTAVQEFQNQMNQLKNKYQGQDEKLWKRSQTFLEKHLNSSHPRSQPAILLLTAARDAEEALRCLSEQIADAYSSFRSVRAIRIDGTDKATQDSDTVKLEVDQELSNGFKNGQNAAVVHRFESFPAGSTLIFYKYCDHENAAFKDVALVLTVLLEEETLGTSLGLKEVEEKVRDFLKVKFTNSNTPNSYNHMDPDKLNGLWSRISHLVLPVQPENALKRGICL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Sulfoxidation-------MAGDGRRA
-------CCCCCHHH
9.4430846556
18PhosphorylationVREGWGVYVTPRAPI
HHCCCEEEECCCCCC
8.4829396449
20PhosphorylationEGWGVYVTPRAPIRE
CCCEEEECCCCCCCC
6.8621815630
39PhosphorylationLAPQNGGSSDAPAYR
CCCCCCCCCCCCCCC
26.8327732954
40PhosphorylationAPQNGGSSDAPAYRT
CCCCCCCCCCCCCCC
40.8627732954
45PhosphorylationGSSDAPAYRTPPSRQ
CCCCCCCCCCCCCCC
17.6025002506
47PhosphorylationSDAPAYRTPPSRQGR
CCCCCCCCCCCCCCC
27.2026055452
50PhosphorylationPAYRTPPSRQGRREV
CCCCCCCCCCCCCEE
38.1426055452
60PhosphorylationGRREVRFSDEPPEVY
CCCEEECCCCCCCCC
30.4221712546
67PhosphorylationSDEPPEVYGDFEPLV
CCCCCCCCCCCHHCC
14.8724173317
76UbiquitinationDFEPLVAKERSPVGK
CCHHCCCCCCCCCCC
46.2929967540
79PhosphorylationPLVAKERSPVGKRTR
HCCCCCCCCCCCCHH
25.6525849741
92PhosphorylationTRLEEFRSDSAKEEV
HHHHHHCCCHHHHHH
41.0425159151
94PhosphorylationLEEFRSDSAKEEVRE
HHHHCCCHHHHHHHH
42.3525159151
102PhosphorylationAKEEVRESAYYLRSR
HHHHHHHHHHHHHHH
15.8228555341
115MethylationSRQRRQPRPQETEEM
HHCCCCCCCCCHHHH
36.88115386881
127PhosphorylationEEMKTRRTTRLQQQH
HHHHHHHHHHHHHHH
16.9929116813
128PhosphorylationEMKTRRTTRLQQQHS
HHHHHHHHHHHHHHC
27.8029116813
135PhosphorylationTRLQQQHSEQPPLQP
HHHHHHHCCCCCCCC
33.3223401153
143PhosphorylationEQPPLQPSPVMTRRG
CCCCCCCCCCCCCCC
19.7122167270
146SulfoxidationPLQPSPVMTRRGLRD
CCCCCCCCCCCCCCC
2.4721406390
147PhosphorylationLQPSPVMTRRGLRDS
CCCCCCCCCCCCCCC
19.9022167270
154PhosphorylationTRRGLRDSHSSEEDE
CCCCCCCCCCCHHHH
20.8729255136
156PhosphorylationRGLRDSHSSEEDEAS
CCCCCCCCCHHHHHH
43.3129255136
157PhosphorylationGLRDSHSSEEDEASS
CCCCCCCCHHHHHHC
39.3129255136
163PhosphorylationSSEEDEASSQTDLSQ
CCHHHHHHCCCCHHH
22.4123927012
164PhosphorylationSEEDEASSQTDLSQT
CHHHHHHCCCCHHHH
44.1123927012
166PhosphorylationEDEASSQTDLSQTIS
HHHHHCCCCHHHHHC
40.6430278072
169PhosphorylationASSQTDLSQTISKKT
HHCCCCHHHHHCHHH
28.2517525332
171PhosphorylationSQTDLSQTISKKTVR
CCCCHHHHHCHHHHC
24.6823927012
173PhosphorylationTDLSQTISKKTVRSI
CCHHHHHCHHHHCHH
31.3323927012
174UbiquitinationDLSQTISKKTVRSIQ
CHHHHHCHHHHCHHH
48.9221906983
174 (in isoform 1)Ubiquitination-48.9221890473
174 (in isoform 2)Ubiquitination-48.9221890473
175UbiquitinationLSQTISKKTVRSIQE
HHHHHCHHHHCHHHH
45.5222817900
176PhosphorylationSQTISKKTVRSIQEA
HHHHCHHHHCHHHHC
25.5323312004
179PhosphorylationISKKTVRSIQEAPVS
HCHHHHCHHHHCCCC
25.0429255136
179 (in isoform 2)Phosphorylation-25.0422777824
179 (in isoform 3)Phosphorylation-25.0422777824
186O-linked_GlycosylationSIQEAPVSEDLVIRL
HHHHCCCCCCEEEEE
25.0830059200
186PhosphorylationSIQEAPVSEDLVIRL
HHHHCCCCCCEEEEE
25.0821712546
187 (in isoform 2)Phosphorylation-56.4528122231
187 (in isoform 3)Phosphorylation-56.4528122231
200PhosphorylationLRRPPLRYPRYEATS
ECCCCCCCCCCCCCC
10.35-
203NitrationPPLRYPRYEATSVQQ
CCCCCCCCCCCCCHH
12.86-
203PhosphorylationPPLRYPRYEATSVQQ
CCCCCCCCCCCCCHH
12.8628796482
206PhosphorylationRYPRYEATSVQQKVN
CCCCCCCCCCHHCCC
19.9327422710
211UbiquitinationEATSVQQKVNFSEEG
CCCCCHHCCCCCCCC
23.2723503661
212UbiquitinationATSVQQKVNFSEEGE
CCCCHHCCCCCCCCC
8.3223503661
215PhosphorylationVQQKVNFSEEGETEE
CHHCCCCCCCCCCCC
29.5429255136
216PhosphorylationQQKVNFSEEGETEED
HHCCCCCCCCCCCCC
66.9227251275
220PhosphorylationNFSEEGETEEDDQDS
CCCCCCCCCCCCCCC
56.3719664994
221PhosphorylationFSEEGETEEDDQDSS
CCCCCCCCCCCCCCC
55.9432645325
227PhosphorylationTEEDDQDSSHSSVTT
CCCCCCCCCCCCEEE
25.0730266825
228PhosphorylationEEDDQDSSHSSVTTV
CCCCCCCCCCCEEEE
35.3622167270
229PhosphorylationEDDQDSSHSSVTTVK
CCCCCCCCCCEEEEE
28.2227251275
230PhosphorylationDDQDSSHSSVTTVKA
CCCCCCCCCEEEEEE
28.5822167270
231PhosphorylationDQDSSHSSVTTVKAR
CCCCCCCCEEEEEEE
20.3322167270
232PhosphorylationQDSSHSSVTTVKARS
CCCCCCCEEEEEEEC
6.1227251275
233PhosphorylationDSSHSSVTTVKARSR
CCCCCCEEEEEEECC
28.0222167270
234PhosphorylationSSHSSVTTVKARSRD
CCCCCEEEEEEECCC
20.1822167270
236UbiquitinationHSSVTTVKARSRDSD
CCCEEEEEEECCCCC
35.6721906983
236 (in isoform 2)Ubiquitination-35.6721890473
237UbiquitinationSSVTTVKARSRDSDE
CCEEEEEEECCCCCC
15.4521963094
237 (in isoform 1)Ubiquitination-15.4521890473
239PhosphorylationVTTVKARSRDSDESG
EEEEEEECCCCCCCC
45.3530242111
242PhosphorylationVKARSRDSDESGDKT
EEEECCCCCCCCCCC
42.0128176443
245PhosphorylationRSRDSDESGDKTTRS
ECCCCCCCCCCCCCC
58.2328176443
248UbiquitinationDSDESGDKTTRSSSQ
CCCCCCCCCCCCHHH
56.1533845483
249PhosphorylationSDESGDKTTRSSSQY
CCCCCCCCCCCHHHH
31.9824247654
249UbiquitinationSDESGDKTTRSSSQY
CCCCCCCCCCCHHHH
31.9833845483
250PhosphorylationDESGDKTTRSSSQYI
CCCCCCCCCCHHHHH
34.0027251275
252PhosphorylationSGDKTTRSSSQYIES
CCCCCCCCHHHHHHH
32.0521712546
253PhosphorylationGDKTTRSSSQYIESF
CCCCCCCHHHHHHHH
20.4027794612
254PhosphorylationDKTTRSSSQYIESFW
CCCCCCHHHHHHHHH
28.4017525332
256PhosphorylationTTRSSSQYIESFWQS
CCCCHHHHHHHHHHH
14.4925884760
259PhosphorylationSSSQYIESFWQSSQS
CHHHHHHHHHHHCCC
23.4023403867
263PhosphorylationYIESFWQSSQSQNFT
HHHHHHHHCCCCCCC
22.4223403867
264PhosphorylationIESFWQSSQSQNFTA
HHHHHHHCCCCCCCC
20.8123403867
266PhosphorylationSFWQSSQSQNFTAHD
HHHHHCCCCCCCCCC
29.1017525332
270O-linked_GlycosylationSSQSQNFTAHDKQPS
HCCCCCCCCCCCCCC
30.5430059200
270PhosphorylationSSQSQNFTAHDKQPS
HCCCCCCCCCCCCCC
30.5423403867
274UbiquitinationQNFTAHDKQPSVLSS
CCCCCCCCCCCHHCC
55.0022817900
275UbiquitinationNFTAHDKQPSVLSSG
CCCCCCCCCCHHCCC
41.3721890473
277PhosphorylationTAHDKQPSVLSSGYQ
CCCCCCCCHHCCCCC
32.9425159151
280PhosphorylationDKQPSVLSSGYQKTP
CCCCCHHCCCCCCCH
21.4025159151
281PhosphorylationKQPSVLSSGYQKTPQ
CCCCHHCCCCCCCHH
37.0425159151
285UbiquitinationVLSSGYQKTPQEWAP
HHCCCCCCCHHHHCC
54.4022817900
286PhosphorylationLSSGYQKTPQEWAPQ
HCCCCCCCHHHHCCC
18.0625159151
286UbiquitinationLSSGYQKTPQEWAPQ
HCCCCCCCHHHHCCC
18.0621890473
287PhosphorylationSSGYQKTPQEWAPQT
CCCCCCCHHHHCCCH
36.8127251275
294PhosphorylationPQEWAPQTARIRTRM
HHHHCCCHHHHHHHH
19.4925159151
300MethylationQTARIRTRMQNDSIL
CHHHHHHHHHCCHHH
18.16115918745
305PhosphorylationRTRMQNDSILKSELG
HHHHHCCHHHHHHHC
37.0523401153
308SumoylationMQNDSILKSELGNQS
HHCCHHHHHHHCCCC
39.9728112733
308UbiquitinationMQNDSILKSELGNQS
HHCCHHHHHHHCCCC
39.9723000965
309PhosphorylationQNDSILKSELGNQSP
HCCHHHHHHHCCCCC
34.3128176443
309UbiquitinationQNDSILKSELGNQSP
HCCHHHHHHHCCCCC
34.3123000965
309 (in isoform 1)Ubiquitination-34.3121890473
315PhosphorylationKSELGNQSPSTSSRQ
HHHHCCCCCCCCCCC
25.4729255136
316PhosphorylationSELGNQSPSTSSRQV
HHHCCCCCCCCCCCC
31.6827251275
317PhosphorylationELGNQSPSTSSRQVT
HHCCCCCCCCCCCCC
46.2823401153
318PhosphorylationLGNQSPSTSSRQVTG
HCCCCCCCCCCCCCC
33.8230266825
319PhosphorylationGNQSPSTSSRQVTGQ
CCCCCCCCCCCCCCC
28.0630266825
320PhosphorylationNQSPSTSSRQVTGQP
CCCCCCCCCCCCCCC
27.1630266825
324PhosphorylationSTSSRQVTGQPQNAS
CCCCCCCCCCCCCCH
23.0426074081
331PhosphorylationTGQPQNASFVKRNRW
CCCCCCCHHHHHCHH
37.8122210691
3342-HydroxyisobutyrylationPQNASFVKRNRWWLL
CCCCHHHHHCHHHHH
41.78-
334AcetylationPQNASFVKRNRWWLL
CCCCHHHHHCHHHHH
41.7826051181
334UbiquitinationPQNASFVKRNRWWLL
CCCCHHHHHCHHHHH
41.7827667366
335UbiquitinationQNASFVKRNRWWLLP
CCCHHHHHCHHHHHH
32.4221890473
335 (in isoform 1)Ubiquitination-32.4221890473
349UbiquitinationPLIAALASGSFWFFS
HHHHHHHHCCEEECC
35.5021890473
350UbiquitinationLIAALASGSFWFFST
HHHHHHHCCEEECCC
22.6621890473
351 (in isoform 2)Ubiquitination-19.4621890473
379PhosphorylationMNQLKNKYQGQDEKL
HHHHHHHHCCCCHHH
27.54-
385AcetylationKYQGQDEKLWKRSQT
HHCCCCHHHHHHHHH
68.8626051181
385UbiquitinationKYQGQDEKLWKRSQT
HHCCCCHHHHHHHHH
68.8629967540
386UbiquitinationYQGQDEKLWKRSQTF
HCCCCHHHHHHHHHH
6.4929967540
399N-linked_GlycosylationTFLEKHLNSSHPRSQ
HHHHHHHCCCCCCCC
40.9819159218
399N-linked_GlycosylationTFLEKHLNSSHPRSQ
HHHHHHHCCCCCCCC
40.9820068230
400O-linked_GlycosylationFLEKHLNSSHPRSQP
HHHHHHCCCCCCCCH
36.0630059200
405PhosphorylationLNSSHPRSQPAILLL
HCCCCCCCCHHHHHH
44.9921712546
424GlutathionylationDAEEALRCLSEQIAD
CHHHHHHHHHHHHHH
5.2222555962
449UbiquitinationIRIDGTDKATQDSDT
EEECCCCCCCCCCCC
53.8524816145
450UbiquitinationRIDGTDKATQDSDTV
EECCCCCCCCCCCCE
17.1924816145
464UbiquitinationVKLEVDQELSNGFKN
EEEEECHHHHHCCCC
50.1024816145
465UbiquitinationKLEVDQELSNGFKNG
EEEECHHHHHCCCCC
3.9124816145
466PhosphorylationLEVDQELSNGFKNGQ
EEECHHHHHCCCCCC
33.8727251275
467PhosphorylationEVDQELSNGFKNGQN
EECHHHHHCCCCCCC
72.9727251275
488PhosphorylationFESFPAGSTLIFYKY
EECCCCCCEEEEEEE
23.3427251275
489PhosphorylationESFPAGSTLIFYKYC
ECCCCCCEEEEEEEC
23.9727251275
539UbiquitinationVRDFLKVKFTNSNTP
HHHHHEEEECCCCCC
44.9029967540
540UbiquitinationRDFLKVKFTNSNTPN
HHHHEEEECCCCCCC
9.7729967540
543PhosphorylationLKVKFTNSNTPNSYN
HEEEECCCCCCCCCC
38.7420068231
556AcetylationYNHMDPDKLNGLWSR
CCCCCHHHCCCHHHH
49.6026051181
556UbiquitinationYNHMDPDKLNGLWSR
CCCCCHHHCCCHHHH
49.6022817900
557UbiquitinationNHMDPDKLNGLWSRI
CCCCHHHCCCHHHHH
8.8421890473
571UbiquitinationISHLVLPVQPENALK
HHHHHCCCCCHHHHH
15.0421890473
572UbiquitinationSHLVLPVQPENALKR
HHHHCCCCCHHHHHC
37.3421890473
5782-HydroxyisobutyrylationVQPENALKRGICL--
CCCHHHHHCCCCC--
46.28-
578UbiquitinationVQPENALKRGICL--
CCCHHHHHCCCCC--
46.2824816145
579UbiquitinationQPENALKRGICL---
CCHHHHHCCCCC---
40.3324816145
593Ubiquitination-----------------
-----------------
24816145
594Ubiquitination------------------
------------------
24816145

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
143SPhosphorylationKinaseCDK2P24941
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TOIP1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TOIP1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
LMNA_HUMANLMNAphysical
16248985
TOR1A_HUMANTOR1Aphysical
20861018
TOR1A_HUMANTOR1Aphysical
15767459
TOR1A_HUMANTOR1Aphysical
23569223
TOR1A_HUMANTOR1Aphysical
25352667
IF4G1_HUMANEIF4G1physical
26496610
PPM1A_HUMANPPM1Aphysical
26496610
THIO_HUMANTXNphysical
26496610
UBP1_HUMANUSP1physical
26496610
AIFM1_HUMANAIFM1physical
26496610
GT2D1_HUMANGTF2IRD1physical
26496610
NARF_HUMANNARFphysical
26496610
CSN7A_HUMANCOPS7Aphysical
26496610
PIGT_HUMANPIGTphysical
26496610
MIC19_HUMANCHCHD3physical
26496610
MREG_HUMANMREGphysical
26496610
IPO4_HUMANIPO4physical
26496610
PEAK1_HUMANPEAK1physical
26496610
MIA40_HUMANCHCHD4physical
26496610
KLH15_HUMANKLHL15physical
28514442
MD2BP_HUMANMAD2L1BPphysical
28514442
AIFM1_HUMANAIFM1physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TOIP1_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry.";
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
J. Proteome Res. 8:651-661(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-399, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-154; SER-156; SER-157;SER-215; THR-220; SER-227 AND SER-305, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-215; THR-220 ANDSER-315, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-135; SER-143; SER-154;SER-156; SER-157; SER-186; SER-215; THR-220; SER-305; SER-315 ANDSER-317, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-143 AND SER-315, ANDMASS SPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-154; SER-156; SER-164;SER-169 AND SER-266, AND MASS SPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-143, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-143; SER-154; SER-163AND THR-220, AND MASS SPECTROMETRY.

TOP